首页> 中文期刊> 《中国生化药物杂志》 >冠心十味丸对离体大鼠心肌缺血再灌注损伤后的保护作用

冠心十味丸对离体大鼠心肌缺血再灌注损伤后的保护作用

         

摘要

目的:研究冠心十味丸对离体大鼠心肌缺血再灌注损伤(MIRI)的保护作用。方法50只Wistar大鼠随机分成正常组、模型组、冠心十味丸低、高剂量组(0.3、0.9 mg/kg)、阳性对照组(复方丹参滴丸处理液),每组各10只。构建离体大鼠心脏再灌注实验模型,测定给药后70 min各组大鼠心肌组织中超氧化物歧化酶( SOD)、乳酸脱氢酶( LDH)、肌酸激酶( CK)、丙二醛( MDA)、Ca2+-ATP酶、Ca2+-Mg2+-ATP酶、Na+-K+-ATP酶的含量。结果与模型组相比,冠心十味丸可明显升高心肌缺血再灌注损伤时SOD、Ca2+-ATP酶、Ca2+-Mg2+-ATP酶、Na+-K+-ATP酶活性( P<0.05或P<0.01),降低缺血再灌注损伤时LDH、CK活性,减少MDA含量(P<0.05或P<0.01)。结论冠心十味丸对离体大鼠心肌缺血;再灌注损伤具有保护作用。%Objective To investigate the protective effect of GuanXinShiWeiWan on ischemia reperfusion(I-R) injury rat.Methods 50 Wistar rats were randomly divided into normal group, model group, GuanXinShiWeiWan low ( 0.3 mg/kg ) and high ( 0.9 mg/kg ) dose group and positive group, each had 10 rats.Adopting the model of ischemia reperfusion injury of isolated rat hearts, the contents of SOD,MDA,LDH,CK and Ca2 +-ATP, Ca2 +-Mg2 +-ATP, Na +-K +-ATP in cardiac muscle tissue were tested and compared.Results Compared with model group, GuanXinShiWeiWan significantly improved the activities of SOD、Ca2 +-ATP,Ca2 +-Mg2 +-ATP and Na +-K +-ATP (P<0.05 or P<0.01) in cardiac muscle tissue which injured by ischemia reperfusion, while reducing markedly the contents of MDA,LDH,CK(P<0.05 or P<0.01).Conclusion GuanXinShiWeiWan can profect the cardiac muscle of ischemia reperfusion.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号